Activity-based Detection of HIF stabilizers: a Future-proof Complementing Method in Doping Control?

Introduction: Small-molecule HIF stabilizers are being misused in sports to ‘artificially’ increase red blood cells. WADA banned their use, but the structural variety in this relatively new class of performance enhancing drugs and the rapid pace at which new drug candidates are emerging hampers thei...

Full description

Saved in:
Bibliographic Details
Main Authors: L.K. Janssens, L. De Wilde, P. Van Eenoo, C.P. Stove
Format: Article
Language:English
Published: Elsevier 2024-12-01
Series:Emerging Trends in Drugs, Addictions, and Health
Online Access:http://www.sciencedirect.com/science/article/pii/S2667118223000491
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850110618724466688
author L.K. Janssens
L. De Wilde
P. Van Eenoo
C.P. Stove
author_facet L.K. Janssens
L. De Wilde
P. Van Eenoo
C.P. Stove
author_sort L.K. Janssens
collection DOAJ
description Introduction: Small-molecule HIF stabilizers are being misused in sports to ‘artificially’ increase red blood cells. WADA banned their use, but the structural variety in this relatively new class of performance enhancing drugs and the rapid pace at which new drug candidates are emerging hampers their detection in biological fluids, as many currently used techniques target specific structures – a problem also encountered with NPS. Therefore, a future-proof strategy was envisaged, capable of detecting ANY HIF stabilizer (known AND unknown ones). Methods: A previously developed cell-based assay, monitoring the upstream mechanism of HIF1 activation (heterodimerization of HIF1α with HIF1β), was used to detect HIF stabilizers in spiked urine samples based on their HIF stabilizing activity. Results: The HIF1 bioassay proved to be universal, detecting every HIF stabilizer tested so far (including enarodustat, IOX2, JNJ-42041935, etc.). Using roxadustat as a prototype compound, sensitivity in known urine matrices was determined and ranged from 1-25 ng/mL. A limit-of-detection in blind-coded roxadustat-spiked urine matrices was determined to evaluate routine applicability of this activity-based detection method. Conclusions: Proof of concept was established that HIF stabilizers can be detected in spiked urine samples by a cell-based assay format through the measurement of increased HIF activation.
format Article
id doaj-art-17dec09ec4aa46e6a179d4f1ae7d21b3
institution OA Journals
issn 2667-1182
language English
publishDate 2024-12-01
publisher Elsevier
record_format Article
series Emerging Trends in Drugs, Addictions, and Health
spelling doaj-art-17dec09ec4aa46e6a179d4f1ae7d21b32025-08-20T02:37:48ZengElsevierEmerging Trends in Drugs, Addictions, and Health2667-11822024-12-01410009810.1016/j.etdah.2023.100098Activity-based Detection of HIF stabilizers: a Future-proof Complementing Method in Doping Control?L.K. Janssens0L. De Wilde1P. Van Eenoo2C.P. Stove3Ghent University, BelgiumGhent University, BelgiumGhent University, BelgiumGhent University, BelgiumIntroduction: Small-molecule HIF stabilizers are being misused in sports to ‘artificially’ increase red blood cells. WADA banned their use, but the structural variety in this relatively new class of performance enhancing drugs and the rapid pace at which new drug candidates are emerging hampers their detection in biological fluids, as many currently used techniques target specific structures – a problem also encountered with NPS. Therefore, a future-proof strategy was envisaged, capable of detecting ANY HIF stabilizer (known AND unknown ones). Methods: A previously developed cell-based assay, monitoring the upstream mechanism of HIF1 activation (heterodimerization of HIF1α with HIF1β), was used to detect HIF stabilizers in spiked urine samples based on their HIF stabilizing activity. Results: The HIF1 bioassay proved to be universal, detecting every HIF stabilizer tested so far (including enarodustat, IOX2, JNJ-42041935, etc.). Using roxadustat as a prototype compound, sensitivity in known urine matrices was determined and ranged from 1-25 ng/mL. A limit-of-detection in blind-coded roxadustat-spiked urine matrices was determined to evaluate routine applicability of this activity-based detection method. Conclusions: Proof of concept was established that HIF stabilizers can be detected in spiked urine samples by a cell-based assay format through the measurement of increased HIF activation.http://www.sciencedirect.com/science/article/pii/S2667118223000491
spellingShingle L.K. Janssens
L. De Wilde
P. Van Eenoo
C.P. Stove
Activity-based Detection of HIF stabilizers: a Future-proof Complementing Method in Doping Control?
Emerging Trends in Drugs, Addictions, and Health
title Activity-based Detection of HIF stabilizers: a Future-proof Complementing Method in Doping Control?
title_full Activity-based Detection of HIF stabilizers: a Future-proof Complementing Method in Doping Control?
title_fullStr Activity-based Detection of HIF stabilizers: a Future-proof Complementing Method in Doping Control?
title_full_unstemmed Activity-based Detection of HIF stabilizers: a Future-proof Complementing Method in Doping Control?
title_short Activity-based Detection of HIF stabilizers: a Future-proof Complementing Method in Doping Control?
title_sort activity based detection of hif stabilizers a future proof complementing method in doping control
url http://www.sciencedirect.com/science/article/pii/S2667118223000491
work_keys_str_mv AT lkjanssens activitybaseddetectionofhifstabilizersafutureproofcomplementingmethodindopingcontrol
AT ldewilde activitybaseddetectionofhifstabilizersafutureproofcomplementingmethodindopingcontrol
AT pvaneenoo activitybaseddetectionofhifstabilizersafutureproofcomplementingmethodindopingcontrol
AT cpstove activitybaseddetectionofhifstabilizersafutureproofcomplementingmethodindopingcontrol